For research use only. Not for therapeutic Use.
TLR4-IN-C34(Cat No.:I011179) is a novel inhibitor belonging to a new class of compounds that target toll-like receptor 4 (TLR4). By inhibiting TLR4, it has the potential to act as an anti-inflammatory drug. Toll-like receptor 4 plays a crucial role in initiating inflammatory responses, and inhibiting its activity can help reduce inflammation. TLR4-IN-C34 offers promise as a therapeutic agent for various inflammatory conditions, providing a new approach to alleviate inflammation-related symptoms and potentially modulate immune responses in diseases such as sepsis, autoimmune disorders, and chronic inflammatory conditions.
Catalog Number | I011179 |
CAS Number | 40592-88-9 |
Synonyms | Alternative Name: TLR4-IN-C34 |
Molecular Formula | C17H27NO9 |
Purity | ≥95% |
Target | Toll-like Receptor (TLR) |
Solubility | Soluble to 50 mM in water and to 100 mM in DMSO |
Storage | -20°C |
IUPAC Name | [(2R,3S,4R,5R,6S)-5-acetamido-3,4-diacetyloxy-6-propan-2-yloxyoxan-2-yl]methyl acetate |
InChI | InChI=1S/C17H27NO9/c1-8(2)24-17-14(18-9(3)19)16(26-12(6)22)15(25-11(5)21)13(27-17)7-23-10(4)20/h8,13-17H,7H2,1-6H3,(H,18,19)/t13-,14-,15-,16-,17+/m1/s1 |
InChIKey | KMIQMFHPUJUDMC-HHARLNAUSA-N |
SMILES | CC(C)OC1C(C(C(C(O1)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C |